Biotech Values

[DewDiligence]

The main difference DNA’s employees are likely to see from Roche’s full takeover (assuming it goes through) is that they will get Roche stock options instead of DNA options. If I were charged with negotiating this deal from DNA’s side, I would demand that Roche list its own shares on a US exchange.